A prospective, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hypertensive women with sexual interest and arousal disorder

Trial Profile

A prospective, open-label 12-weeks treatment study to determine the effect of tadalafil 5 mg on clitoral blood flow in menopausal and hypertensive women with sexual interest and arousal disorder

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Sponsors Laboratorios Litaphar
  • Most Recent Events

    • 22 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top